3rd-5th November 2014
We will be partnering and exhibiting at BioEurope. Please contact us via the Partnering system to arrange a meeting.
3rd-7th November 2014
PEGS Europe, Lisbon
Dr Koen Hellendoorn will be attending PEGS from 5-7 November. Please contact us to arrange a meeting.
10th-12th November 2014
European Antibody Congress, Geneva
We are pleased to be Gold Sponsors at European Antibody Congress. In addition to exhibiting, Bo Kara will be presenting in the ADC track : "ADCs - gene to drug product"
25th-26th November 2014
bioProcess UK, Liverpool
We are pleased to sponsor bioProcess UK, where we will be exhibiting.
7-11 December 2014
IBC Antibody Engineering, Huntington Beach, CA
Webinar : The Single-use Technology Paradigm
Click on the link below to listen to Dr Stewart McNaull presenting a webinar entitled 'The Single-use Technology Paradigm' as part of Business Review Webinars' Knowledge Sharing series.
Webinar : How to get industry leading titers of protein in E.Coli
The development of large scale E. coli expression systems can be rate limiting in process development, because many standard expression systems do not scale up easily and often require extensive product specific fermentation process development.
Click the link in the box below to view the On Demand version of the webinar.
Webinar : Automating final filtration & dispensing of biologics in a closed single-use system
Dr Paul Bird, Head of Manufacturing Engineering, co-presented a case study in this webinar with Parker Domnick Hunter on 25th June 2014. You can listen to this 'on demand' via the link below
Webinar : Process Development studies for Product Commercialisation
Join us for an 'On Demand' webinar led by Dr Graham McCreath (Head of Process Design); Dr Mahesh Shivhare (Senior Process Statistician) and Dr. Simon Hanslip (Senior Technical Project Leader). The webinar discusses activities for successful Process Characterisation and Process Validation.
Webinar : A One Stop Shop Solution for Manufacture of ADCs
ADCs are showing great promise as a new therapeutic entity, but have a complex supply chain requiring biologics and high potency capability. This joint presentation from ourselves and our strategic partner Piramal Healthcare demonstrates our integrated approach for rapid delivery of ADCs.
Click on the link below to view the On Demand webinar.